Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigs

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yang, Shu Lin ^a   Xia, Ji Han ^a   Zhang, Yuan Yuan ^b   Fan, Jian Gao ^c   Wang, Hua ^d   Yuan, Jing ^a,e   Zhao, Zhan Zhao ^b   Pan, Qin ^c   Mu, Yu Lian ^a   Xin, Lei Lei ^a   Chen, Yao Xing ^b   Li, Kui ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

^e YANGTZE UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; FATTY ACID; GLUCOSE; KETONE BODY; TRANSCRIPTOME; TRIACYLGLYCEROL;

ANIMAL; BLOOD; BODY WEIGHT; COMPLICATION; DISEASE MODEL; DNA DAMAGE; FIBROSIS; GENE EXPRESSION PROFILING; HYPERINSULINISM; HYPERPLASIA; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; LIVER CELL; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PANCREAS ISLET; PATHOLOGY; PHENOTYPE; PIG; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CHOLESTEROL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DNA DAMAGE; FATTY ACIDS; FIBROSIS; GENE EXPRESSION PROFILING; GLUCOSE; HEPATOCYTES; HYPERINSULINISM; HYPERPLASIA; INSULIN RESISTANCE; ISLETS OF LANGERHANS; KETONE BODIES; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PHENOTYPE; SWINE; TRANSCRIPTOME; TRIGLYCERIDES;

EID: 84941584703     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13980     Document Type: Article

References (54)

1. Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10, 686-690 (2013).
2. Tiniakos, D. G., Vos, M. B. & Brunt, E. M. Nonalcoholic fatty liver disease. pathology and pathogenesis. Annu Rev Pathol 5, 145-171 (2010).
3. Day, C. P. & James, O. F. Steatohepatitis. a tale of two hits? Gastroenterology 114, 842-845 (1998).
4. Cohen, J. C., Horton, J. D. & Hobbs, H. H. Human fatty liver disease. old questions and new insights. Science 332, 1519-1523 (2011).
5. Dowman, J. K., Tomlinson, J. W. & Newsome, P. N. Pathogenesis of non-alcoholic fatty liver disease. QJM 103, 71-83 (2010).
6. Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836-1846 (2010).
7. Begriche, K., Massart, J., Robin, M. A., Bonnet, F. & Fromenty, B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 58, 1497-1507 (2013).
8. Dongiovanni, P., Fracanzani, A. L., Fargion, S. & Valenti, L. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol 55, 920-932 (2011).
9. Turchi, C. et al. ADH4 intronic variations are associated with alcohol dependence: results from an Italian case-control association study. Pharmacogenet Genomics 22, 79-94 (2012).
10. Abdelmegeed, M. A. et al. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. J Hepatol 57, 860-866 (2012).
11. Lopez-Vicario, C. et al. Molecular interplay between Delta5/Delta6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. Gut 63, 344-355 (2014).
12. Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. & Tiribelli, C. Molecular basis and mechanisms of progression of nonalcoholic steatohepatitis. Trends Mol Med 14, 72-81 (2008).
13. Hebbard, L. & George, J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 8, 35-44 (2011).
14. Kohli, R. & Feldstein, A. E. NASH animal models: are we there yet? J Hepatol 55, 941-943 (2011).
15. Lewis, J. R. & Mohanty, S. R. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 55, 560-578 (2010).
16. Spurlock, M. E. & Gabler, N. K. The development of porcine models of obesity and the metabolic syndrome. J Nutr 138, 397-402 (2008).
17. Litten-Brown, J. C., Corson, A. M. & Clarke, L. Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview. Animal 4, 899-920 (2010).
18. Groenen, M. A. M. et al. Analyses of pig genomes provide insight into porcine demography and evolution. Nature 491, 393-398 (2012).
19. Larsen, M. O., Rolin, B., Wilken, M., Carr, R. D. & Svendsen, O. High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Gottingen minipig - Results from a pilot study. Ann Ny Acad Sci 967, 414-423 (2002).
20. Sebert, S. P. et al. Obesity induced during sexual maturation is linked to LDL-triacylglycerols in Yucatan miniature swine. Brit J Nutr 94, 282-289 (2005).
21. Dyson, M. C., Alloosh, M., Vuchetich, J. P., Mokelke, E. A. & Sturek, M. Components of metabolic syndrome and coronary artery disease in female ossabaw swine fed excess atherogenic diet. Comparative Med 56, 35-45 (2006).
22. Lee, L. et al. Nutritional Model of Steatohepatitis and Metabolic Syndrome in the Ossabaw Miniature Swine. Hepatology 50, 56-67 (2009).
23. Chen, H., Liu, Y. Q., Li, C. H., Guo, X. M. & Huang, L. J. The susceptibility of three strains of chinese minipigs to diet-induced type 2 diabetes mellitus. Lab Animal 38, 355-363 (2009).
24. Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321 (2005).
25. Calamita, G. et al. Aquaporins and glycerol metabolism in health and disease. Translational value in liver steatosis and obesity. European Journal of Clinical Investigation 44, 76-76 (2014).
26. Maeda, N. Implications of aquaglyceroporins 7 and 9 in glycerol metabolism and metabolic syndrome. Molecular Aspects of Medicine 33, 665-675 (2012).
27. Cao, W. et al. Acetyl-coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines. Bba-Gen Subjects 1780, 873-880 (2008).
28. Shafqat, N., Turnbull, A., Zschocke, J., Oppermann, U. & Yue, W. W. Crystal Structures of Human HMG-CoA Synthase Isoforms Provide Insights into Inherited Ketogenesis Disorders and Inhibitor Design. Journal of Molecular Biology 398, 497-506 (2010).
29. Jacobi, S. K. et al. Dietary Arachidonate Differentially Alters Desaturase-Elongase Pathway Flux and Gene Expression in Liver and Intestine of Suckling Pigs. Journal of Nutrition 141, 548-553 (2011).
30. Tikhonenko, M. et al. Remodeling of Retinal Fatty Acids in an Animal Model of Diabetes A Decrease in Long-Chain Polyunsaturated Fatty Acids Is Associated With a Decrease in Fatty Acid Elongases Elovl2 and Elovl4. Diabetes 59, 219-227 (2010).
31. Song, H. et al. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism. Am J Physiol-Endoc M 290, E17-E25 (2006).
32. Turro, S. et al. Identification and characterization of associated with lipid droplet protein 1: A novel membrane-associated protein that resides on hepatic lipid droplets. Traffic 7, 1254-1269 (2006).
33. Le Borgne, F., Ben Mohamed, A., Logerot, M., Garnier, E. & Demarquoy, J. Changes in carnitine octanoyltransferase activity induce alteration in fatty acid metabolism. Biochem Bioph Res Co 409, 699-704 (2011).
34. Braissant, O. et al. Creatine synthesis and transport during rat embryogenesis: Spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev Biol 5, 9 (2005).
35. Anselm, I. A., Coulter, D. L. & Darras, B. T. Cardiac manifestations in a child with a novel mutation in creatine transporter gene SLC6A8. Neurology 70, 1642-1644 (2008).
36. Richard I., Devaud C., Cherif D., Cohen D., Beckmann J. S. The gene for creatine kinase, mitochondrial 2 (sarcomeric; CKMT2), maps to chromosome 5q13.3. Genomics 18, 134-136 (1993).
37. Schmidt, A. et al. Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet 13, 905-921 (2004).
38. Leung, T. M. & Nieto, N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol 58, 395-398 (2013).
39. Baker, S. S., Baker, R. D., Liu, W., Nowak, N. J. & Zhu, L. Role of alcohol metabolism in non-alcoholic steatohepatitis. PLoS One 5, e9570 (2010).
40. Sass, D. A., Chang, P. & Chopra, K. B. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 50, 171-180 (2005).
41. Simons, K. & Ikonen, E. Cell biology-How cells handle cholesterol. Science 290, 1721-1726 (2000).
42. Tilg, H. & Moschen, A. R. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrin Met 19, 371-379 (2008).
43. Trak-Smayra, V. et al. Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. International Journal of Experimental Pathology 92, 413-421 (2011).
44. Zammit, V. A. Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia. Biochemical Journal 451, 1-12 (2013).
45. Mannisto, V. T. et al. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. Liver International, doi: 10.1111/liv.12769 (2015).
46. Roman, R. J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82, 131-185 (2002).
47. Caro, A. A. & Cederbaum, A. I. Role of cytochrome P450 in phospholipase A2-and arachidonic acid-mediated cytotoxicity. Free Radical Bio Med 40, 364-375 (2006).
48. Sumida, Y., Yoshikawa, T. & Okanoue, T. Role of hepatic iron in non-alcoholic steatohepatitis. Hepatology Research 39, 213-222 (2009).
49. Wang, B. T. et al. The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile. P Natl Acad Sci USA 108, 15201-15206 (2011).
50. Kang, H. S. et al. Early growth response protein 1 upregulation and nuclear translocation by 2 -benzoyloxycinnamaldehyde induces prostate cancer cell death. Cancer Lett 329, 217-227 (2013).
51. Fan, F. Y. et al. ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 21, 7488-7496 (2002).
52. Oshlack, A., Robinson, M. D. & Young, M. D. From RNA-seq reads to differential expression results. Genome Biol 11, 220 (2010).
53. Roberts, A., Trapnell, C., Donaghey, J., Rinn, J. L. & Pachter, L. Improving RNA-Seq expression estimates by correcting for fragment bias. Genome Biol 12, R22 (2011).
54. Rapaport, F. et al. Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data. Genome Biol 14, R95 (2013).